Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.15
-0.02 (-0.39%)
Jan 22, 2025, 2:45 PM EST - Market open
Orchestra BioMed Holdings Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$15.80
Upside
+206.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $16 | Buy | Initiates | $16 | +210.68% | Jan 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +171.84% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +288.35% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +171.84% | Aug 22, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +191.26% | Jul 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +288.35% | Jun 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +288.35% | Mar 28, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +171.84% | Jan 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +288.35% | Aug 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +288.35% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +288.35% | May 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $15 | Buy | Initiates | $15 | +191.26% | Feb 24, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +288.35% | Feb 7, 2023 |